Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2

Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, Johannes Lars Isaksson, Carlo Pietro Soatti, Luigi Franco Cazzaniga, Giovanni Battista Ivaldi, Marcello Amadori, Paolo Antognoni, Stefano Arcangeli, Alberto Buffoli, Giancarlo Beltramo, Mario Bignardi, Stefano Bracelli, Lorenza Bruschieri, Simona Castiglioni, Gianpiero Catalano, Nadia Di Muzio, Carlo Fallai, Laura FariselliAndrea Riccardo Filippi, Alberto Gramaglia, Corrado Italia, Fabrizio Lombardi, Stefano Maria Magrini, Simonetta Nava, Ester Orlandi, Nadia Pasinetti, Elena Lara Sbicego, Luciano Scandolaro, Marta Scorsetti, Francesco Stiglich, Roberto Tortini, Riccardo Valdagni, Vittorio Vavassori, Sandro Tonoli, Mauro Filippo Palazzi, on behalf of the CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network and of AIRO-L (Italian Association of Radiotherapy and Clinical Oncology – Lombardy)

Research output: Contribution to journalArticlepeer-review

Abstract

Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery.
Original languageEnglish
JournalMedical Oncology
Volume37
Issue number11
DOIs
Publication statusPublished - 2020

Fingerprint Dive into the research topics of 'Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2'. Together they form a unique fingerprint.

Cite this